• About Norgine
  • Careers
  • Products
  • Norgine Development
  • Finance
  • Business Development
  • Media

Latest News Releases

APR Applied Pharma Research s.a. (“APR”), Labtec GmbH (“Labtec”) and Norgine BV (“Norgine”) announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm™ Ondansetron Oral Dispersible Film

More...


view all news releases

As a leading European specialty pharmaceutical company, Norgine develops, manufactures and markets innovative medicines for the benefit of patients, employees and all other stakeholders

 

 


Corporate Web Site
Terms and Conditions | Disclaimer | Contacts